MétaCan
Menu
Retour à la cohorte
Enregistrement W4381249225 · doi:10.1016/j.jhep.2023.04.035

A global research priority agenda to advance public health responses to fatty liver disease

2023· article· en· W4381249225 sur OpenAlexaff
Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Saleh A. Alqahtani, Marco Arrese, Ramón Bataller, Thomas Berg, Paul Brennan, Patrizia Burra, Graciela Castro‐Narro, Helena Cortez‐Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven Francque, Hannes Hagström, Terry T.‐K. Huang, Dana Ivancovsky‐Wajcman, Christopher J. Kopka, Aleksander Krag, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, C Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Fredrik Åberg, Leon A. Adams, Khalid Al‐Naamani, Reda Albadawy, Zinaida Alexa, Michael Allison, Faisal Abdullatif Alnaser, Khalid Alswat, Mário Reis Álvares‐da‐Silva, Domenico Alvaro, Michele Alves‐Bezerra, Raúl J. Andrade, Quentin M. Anstee, Yaw Asante Awuku, Oidov Baatarkhuu, György Baffy, Shokhista Bakieva, Meena B. Bansal, Robert Barouki, Rachel L. Batterham, Cynthia Behling, Renata Belfort‐DeAguiar, Annalisa Berzigotti, Michael Betel, Cristiana Bianco, Emanuele Bosi, Jérôme Boursier, Elizabeth M. Brunt, Elisabetta Bugianesi, Christopher J. Byrne, María Cecilia Cabrera Cabrejos, Stephen Caldwell, Rotonya M. Carr, Laurent Castéra, Maria Gabriela Castillo-López, Cyrielle Caussy, Eira Cerda‐Reyes, Antonio Ceriello, Wah‐Kheong Chan, Yoosoo Chang, Phunchai Charatcharoenwitthaya, Norberto C. Chávez‐Tapia, Raymond T. Chung, Massimo Colombo, Kirsten J. Coppell, Helma Pinchemel Cotrim, Antonio Craxı̀, Javier Crespo, Anuradha Supun Dassanayake, Nicholas O. Davidson, Robert J. de Knegt, Victor de Lédinghen, Münevver Demir, Hailemichael Desalegn, M. Diago, John Dillon, Bruce Dimmig, M. Ashworth Dirac, Melisa Dirchwolf, Jean‐François Dufour, Karel Dvořák, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Ahmed M. Elsharkawy, Reda Elwakil, Wayne Eskridge, Mohammed Eslam, Gamal Esmat, Jian‐Gao Fan, Maria Lúcia Gomes Ferraz, Robert Flisiak, Davide Fortin, Yasser Fouad, S L Freĭdman, Michael Fuchs, Adrián Gadano, Amalia Gastaldelli, Anja Geerts, Andreas Geier, Jacob George, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, Denise Giangola Kile, Marcos Girala, Nicolas Goossens, Isabel Graupera, Henning Grønbæk, Saeed Hamid, Vanessa Hebditch, Zachary Henry, Ingrid J. Hickman, L. Ansley Hobbs, Samantha Hocking, Wolf Peter Hofmann, Ramazan Idılman, Paula Iruzubieta, Scott Isaacs, Isakov Va, Mona Ismail, Mohammad H. Jamal, Helen Jarvis, Peter Jepsen, François R. Jornayvaz, K. C. Sudhamshu, Satoru Kakizaki, Saul J. Karpen, Takumi Kawaguchi, Shelley E. Keating, Yousef Khader, Seung Up Kim, Won Kim, David E. Kleiner, Ger H. Koek, Narcisse Komas, Loreta A. Kondili, Bart G.P. Koot, Marko Korenjak, Eleni Kotsiliti, Yiannoula Koulla, Carina Kugelmas, Marcelo Kugelmas, Asma Labidi, Naomi F. Lange, Joel E. Lavine, Mariana Lazo, Nathalie C. Leite, Han‐Chieh Lin, Undram Lkhagvaa, Michelle T. Long, Patricio López‐Jaramillo, Adelina Lozano, Maria Paula Macedo, Reza Malekzadeh, Giulio Marchesini, Sebastián Marciano, Kim Martínez, S Vázquez, Lyudmila Mateva, José M. Mato, Charles Mbendi Nlombi, Alexis Gorden McCary, Jeff McIntyre, Martin McKee, Juan Manuel Mendive, Ivana Mikolašević, Pamela S. Miller, Terri Milton, R. Moreno-Alcántar, Timothy R. Morgan, Ayesha A. Motala, Jean Muris, Carla Musso, Edna J. Nava‐González, Francesco Negro, Alexander Nersesov, Brent A. Neuschwander‐Tetri, Dafina Nikolova, Suzanne Norris, Katja Novak, Ponsiano Ocama, Janus P. Ong, Arlinking Ong-Go, Charles Onyekwere, Martín Padilla, Raluca Pais, Calvin Q. Pan, Arturo Panduro, Manas Kumar Panigrahi, Imran Paruk, Keyur Patel, Carlos Penha‐Gonçalves, Marlene Pérez Figueroa, Juanita Pérez-Escobar, Juan M. Pericàs, Gianluca Perseghin, Mário Guimarães Pessôa, Salvatore Petta, Cláudia P. Oliveira, Dorairaj Prabhakaran, Nikolaos Pyrsopoulous, Atoosa Rabiee, Alnoor Ramji, Vlad Ratziu, Natarajan Ravendhran, Katrina Ray, Michael Roden, Stefano Romeo, Manuel Romero‐Gómez, Yaron Rotman, Samir Rouabhia, Ian Rowe, Shakhlo Sadirova, Maryam Alkhatry, Riina Salupere, Sanjaya K. Satapathy, Jeffrey B. Schwimmer, Giada Sebastiani, Lynn Seim, Yosuke Seki, Abdel Karim Sermé, Д. А. Шапиро, Lali Sharvadze, Jonathan E. Shaw, Isaac Thom Shawa, Oren Shibolet, Yusuke Shimakawa, Jay H. Shubrook, Shivaram Prasad Singh, Edford Sinkala, Ľubomír Skladaný, Ігор Миколайович Скрипник, Myeong Jun Song, Silvia Sookoian, Kannan Sridharan, Norbert Stefan, Jonathan G. Stine, Dhastagir Sultan Sheriff, Shikha S. Sundaram, Gianluca Svegliati‐Baroni, Mark G. Swain, Frank Tacke, Shahrad Taheri, Soek-Siam Tan, Elliot B. Tapper, Giovanni Targher, Eugen Tcaciuc, Maja Thiele, Dina Tiniakos, Ieva Tolmane, Aldo Torre, Esther A. Torres, Sombat Treeprasertsuk, Michael I. Trenell, Svetlana Turcan, Adela Turcanu, Jonas Valantinas, Laurens A. van Kleef, J.A. Velarde-Ruiz Velasco, Mette Vesterhus, Eduardo Vilar‐Gómez, Imam Waked, Julia Wattacheril, Heiner Wedemeyer, Fonda Wilkins, José Willemse, Robert J. Wong, Yusuf Yılmaz, Hannele Yki‐Järvinen, Ming‐Lung Yu, Volkan Yumuk, Müjdat Zeybel, Kenneth I. Zheng, Ming‐Hua Zheng

Notice bibliographique

RevueJournal of Hepatology · 2023
Typearticle
Langueen
DomaineMedicine
ThématiqueLiver Disease Diagnosis and Treatment
Établissements canadiensLondon Health Sciences CentreWestern University
Organismes subventionnairesNovartis PharmaCenters for Disease Control and PreventionNorgineLG ChemIpsenSun PharmaUnited European GastroenterologyNovo Nordisk FondenEuropean Association for the Study of the LiverSyddansk UniversitetArrowhead PharmaceuticalsDanmarks GrundforskningsfondNational Research FoundationEuropean Association for the Study of DiabetesNovo NordiskNational Institute for Health and Care ResearchEuropean Foundation for the Study of DiabetesIntercept PharmaceuticalsAstraZenecaBarts CharityRegeneron PharmaceuticalsGilead SciencesMedical Research CouncilEA Pharma Co., Ltd.InnovationsfondenInventiva PharmaPfizerAmerican Association for the Study of Liver DiseasesGlaxoSmithKlineNational Institute of Diabetes and Digestive and Kidney DiseasesSanofiEli Lilly and Company
Mots-clésPublic healthFatty liverEnvironmental healthDiseasePolitical scienceBusinessMedicineInternal medicinePathology

Résumé

récupéré en direct d'OpenAlex

BACKGROUND & AIMS: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. METHODS: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. RESULTS: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of 'agree' responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement ('agree' + 'somewhat agree'); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% 'agree'), 13 priorities had <80% 'agree', with greater reliance on 'somewhat agree' to achieve >90% combined agreement. CONCLUSIONS: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community's efforts to advance and accelerate responses to this widespread and fast-growing public health threat. IMPACT AND IMPLICATIONS: An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,002
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,088
Score d'incertitude au seuil0,461

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,002
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0010,001
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,176
Tête enseignante GPT0,464
Écart entre enseignants0,288 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations132
Publié2023
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueJournal of HepatologyMême sujetLiver Disease Diagnosis and TreatmentTravaux en français237 207